Recent advances in the treatment of visceral leishmaniasis
- 1 March 1993
- journal article
- review article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 87 (2) , 130-141
- https://doi.org/10.1016/0035-9203(93)90457-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antileishmanial activity of the ether phospholipid ilmofosineTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasisAntimicrobial Agents and Chemotherapy, 1992
- Drug Resistance in Leishmaniasis: Its Implication in Systemic Chemotherapy of Cutaneous and Mucocutaneous DiseaseThe American Journal of Tropical Medicine and Hygiene, 1992
- Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical StudiesThe American Journal of Tropical Medicine and Hygiene, 1992
- Liposomal amphotericin B in drug-resistant visceral leishmaniasisThe Lancet, 1991
- Liposomal amphotericin B in the treatment of visceral leishmaniasisJournal of Antimicrobial Chemotherapy, 1991
- Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in ItalyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Leishmania spp.: Development of pentostam-resistant clones in vitro by discontinuous drug exposureExperimental Parasitology, 1989
- Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeysAntimicrobial Agents and Chemotherapy, 1986